Ajai Chari, MD, Talks Talquetamab for Relapsed/Refractory MM


In this video, Dr Chari discusses the findings of a phase 1 trial examining the use of talquetamab in heavily pretreated patients with relapsed or refractory multiple myeloma (MM).

4 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Stay in the know.
OncNet Newsletter